Ingredients

The main ingredient of this product is sitagliptin phosphate.

product-800-533

Character

This product is a film coated tablet, which appears white or off white after removing the coating.

Indication

Monotherapy

This product is used in combination with diet control and exercise to improve blood sugar control in patients with type 2 diabetes.

Combined with Metformin

When metformin hydrochloride alone has poor blood glucose control, it can be used together with metformin hydrochloride to improve the blood glucose control of type 2 diabetes patients on the basis of diet and exercise.

Combined use with sulfonylurea drugs

This product, together with diet control and exercise, is used to improve the blood sugar control of type 2 diabetes patients with poor blood sugar control after a single sulfonylurea drug treatment or a sulfonylurea drug combined with metformin treatment.

Combined with insulin

This product, together with diet control and exercise, is used to improve the blood sugar control of type 2 diabetes patients with poor blood sugar control after insulin monotherapy or insulin combined with metformin treatment.

Specifications

100mg (calculated as sitagliptin)

Usage and dosage

The recommended dosage for monotherapy or combination therapy with metformin, or combination therapy with sulfonylurea drugs (with or without metformin), or combination therapy with insulin (with or without metformin) is 100 mg once daily. This product can be taken with or without food.

When this product is used in combination with a sulfonylurea drug or insulin, it is necessary to consider reducing the dose of sulfonylurea drug or insulin to reduce the risk of hypoglycemia caused by sulfonylurea drug or insulin. (See precautions for hypoglycemia when used in combination with a sulfonylurea drug or insulin).

Patients with renal impairment

Renal function should be evaluated before starting treatment with this product, and regular assessments should be conducted after starting treatment.

When patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and<90mL/min/1.73 m2) take this product, no adjustment is required